| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Gastroenterology Research Unit and 2 Section of Biostatistics, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905
The cholinesterase inhibitor neostigmine indirectly stimulates muscarinic M1/M2/M3 receptors, thereby reducing colonic distension in acute colonic pseudo-obstruction. We investigated the dose-response profile for the colonic sensorimotor effects of neostigmine and bethanechol, a direct muscarinic M2/M3 agonist in humans. A barostat-manometric assembly recorded phasic pressures, tone, and pressure-volume relationships (compliance) in the descending colon and rectum of 30 healthy subjects who received intravenous neostigmine (0.25, 0.75, or 1.5 mg; n = 15) or subcutaneous bethanechol (2.5, 5, or 10 mg; n = 15). Sensation to luminal distension was also assessed. Thereafter, the effects of neostigmine and bethanechol on colonic transit (geometric center) were compared with those of saline by scintigraphy in 21 subjects. Both drugs increased colonic phasic pressure activity, reduced rectal compliance, and enhanced urgency during rectal distension. Neostigmine also reduced colonic and rectal balloon volumes, reflecting increased tone by an average of 12% and 25% for the highest dose, respectively. Only neostigmine reduced colonic compliance, accelerated colonic transit [mean geometric center at 90 min 2.5 vs. 1.0 (placebo)], and increased pain perception during colonic distension. We conclude that neostigmine has more prominent colonic motor and sensory effects than bethanechol. Moreover, neostigmine induces coordinated colonic propulsion, perhaps by stimulating muscarinic M1 receptors in the myenteric plexus.
colonic tone; sensation; compliance; neostigmine; bethanechol
This article has been cited by other articles:
|
|
 |
|
  I. F. Btaiche, L.-N. Chan, M. Pleva, and M. D. Kraft Critical Illness, Gastrointestinal Complications, and Medication Therapy during Enteral Feeding in Critically Ill Adult Patients Nutr Clin Pract, February 1, 2010; 25(1): 32 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Gourcerol, L. Wang, D. W. Adelson, M. Larauche, Y. Tache, and M. Million Cholinergic giant migrating contractions in conscious mouse colon assessed by using a novel noninvasive solid-state manometry method: modulation by stressors Am J Physiol Gastrointest Liver Physiol, May 1, 2009; 296(5): G992 - G1002. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Bharucha, A. J. Croak, J. B. Gebhart, L. J. Berglund, B. M. Seide, A. R. Zinsmeister, and K.-N. An Comparison of rectoanal axial forces in health and functional defecatory disorders Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1164 - G1169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A E Bharucha, J G Fletcher, C M Harper, D Hough, J R Daube, C Stevens, B Seide, S J Riederer, and A R Zinsmeister Relationship between symptoms and disordered continence mechanisms in women with idiopathic faecal incontinence Gut, April 1, 2005; 54(4): 546 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Delgado-Aros, H. J. Chial, M. Camilleri, L. A. Szarka, F. T. Weber, J. Jacob, I. Ferber, S. McKinzie, D. D. Burton, and A. R. Zinsmeister Effects of a kappa -opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans Am J Physiol Gastrointest Liver Physiol, April 1, 2003; 284(4): G558 - G566. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
